Abstract
Background
significance of incidental thyroid 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake on positron emission tomography/computed tomography (PET/CT) scans remains controversial. We aimed to evaluate the ability of [18F]FDG-PET/CT texture analysis to predict final diagnosis in thyroid incidentaloma.
Methods
We retrospectively evaluated medical records of all patients who performed a [18F]FDG-PET/CT from January 2012 to October 2016. Those patients who presented a thyroid incidentaloma described in the medical records and performed a fine needle aspiration in our institution were considered for the analysis. Cytological and/or histological results were used as reference standard to define the final diagnosis. In case of negative cytology, the nodule was considered benign. In case of non-diagnostic or inconclusive results ultrasound, follow-up and further cytology/histology were used as final diagnosis. For suspected or positive cytological result, histology was used as reference standard. PET images were segmented using a General Electric AW workstation running PET VCAR software (GE Healthcare, Waukesha, WI, USA) settled with a threshold of 40% SUVmax. LifeX software (
Results
We identified 55 patients with incidental thyroid [18F]FDG uptake. Five patients were excluded from the analysis because a final diagnosis was not available. Thirty-two out of 50 patients had benign nodules while in 18/50 cases a malignancy (primary thyroid cancer = 15, metastases = 3) was diagnosed. Conventional PET parameters and histogram-based features were calculated for all 50 patients, while other matrices-based features were available for 28/50 patients. SUVmax and skewness resulted significantly different in benign and malignant nodules (p = 0.01 and = 0.02, respectively). Using ROC analysis, seven features were identified as potential predictors. Among all the textural features tested, skewness showed the best area under the curve (= 0.66). SUV-based parameters resulted in the highest specificity while MTV, TLG, skewness and kurtosis, as well as correlationGLCM resulted better in sensitivity.
Conclusions
[18F]FDG-PET/CT texture analysis seems to be a promising approach to stratify the patients with thyroid incidentaloma identified on PET scans, with respect to the risk of the diagnosis of a malignant thyroid nodule and thus, could refine the selection of the patients to be referred for cytology.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Cozzi, L. 2 ; Pepe, G. 3 ; Antunovic, L. 3 ; Lania, A. 4 ; Di Tommaso, L. 5 ; Magnoni, P. 6 ; Erba, P. A. 7 ; Kirienko, M. 1 1 Humanitas University, Department of Biomedical Sciences, Pieve Emanuele (Milan), Italy (GRID:grid.452490.e)
2 Humanitas Clinical and Research Center, Radiotherapy and Radiosurgery, Rozzano (Milan), Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807); Humanitas University, Department of Biomedical Sciences, Pieve Emanuele (Milan), Italy (GRID:grid.452490.e)
3 Humanitas Clinical and Research Center, Nuclear Medicine, Rozzano (Milan), Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807)
4 Humanitas University, Department of Biomedical Sciences, Pieve Emanuele (Milan), Italy (GRID:grid.452490.e); Endocrinology, Humanitas Clinical and Research Center, Rozzano (Milan), Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807)
5 Humanitas University, Department of Biomedical Sciences, Pieve Emanuele (Milan), Italy (GRID:grid.452490.e); Pathology, Humanitas Clinical and Research Center, Rozzano (Milan), Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807)
6 Ultrasound Service, Humanitas Clinical and Research Center, Rozzano (Milan), Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807)
7 University of Pisa, Regional Center of Nuclear Medicine, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729)




